CRIS
Permanent URI for this communityhttps://investigadores.udd.cl/handle/123456789/1
Browse
4 results
Search Results
Now showing 1 - 4 of 4
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Enfermedad relacionada a IgG4. Serie clínica de pacientes chilenos(2022) ;María C. Cuéllar ;Miguel Gutiérrez ;Alejandra Herrera ;Fabián ElguetaPamela WurmannScopus© Citations 1 4 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?(2020); ;Oriela Martínez ;Francisca Valenzuela ;Francisco Silva44 1Scopus© Citations 38 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis(2020) ;Gwen E. Thompson ;Lynn A. Fussner ;Amber M. Hummel ;Darrell R. SchroederFrancisco Silva14Scopus© Citations 19 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, A Multicenter Study To Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Lineage(2019) ;Ayesha Khan ;Lina M. Rivas ;Maria Spencer ;Rodrigo MartinezMarusella Lam<jats:p> Ceftaroline (CPT) is a broad-spectrum agent with potent activity against methicillin-resistant <jats:named-content content-type="genus-species">Staphylococcus aureus</jats:named-content> (MRSA). The sequence type 5 (ST5) Chilean-Cordobés clone, associated with CPT nonsusceptibility, is dominant in Chile, a region with high rates of MRSA infections. </jats:p>1Scopus© Citations 7 1